The mechanics behind this debate—I was planning to say that my noble friend Lord Lansley made this point—are about the alignment of the voluntary and statutory schemes. I think that we would all agree that it is sensible that the two are roughly aligned. We can argue over how high or low that figure should be, but we would agree, I think, that it is quite sensible that the two are aligned. If you had large disparities between the two, you would disadvantage, for instance, the members who have joined the VPAS system.
Branded Health Service Medicines (Costs) (Amendment) Regulations 2023
Proceeding contribution from
Lord Markham
(Conservative)
in the House of Lords on Thursday, 25 May 2023.
It occurred during Debates on delegated legislation on Branded Health Service Medicines (Costs) (Amendment) Regulations 2023.
Type
Proceeding contribution
Reference
830 c1031 
Session
2022-23
Chamber / Committee
House of Lords chamber
Subjects
Librarians' tools
Timestamp
2023-05-26 10:38:25 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000005
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000005
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000005